Skip to content

Clinical trial of local application of herbal paste on the infected wound.

Randomized open controlled clinical study to evaluate the sodhan and ropan effect of tilakalkadi lepa in dushta vrana with special reference to infected wound.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053118
Enrollment
60
Registered
2023-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S00-T88- Injury, poisoning and certain other consequences of external causes

Interventions

None listed

Sponsors

Dr Shekhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient having sign and symptoms of Dushtavrana(infected wound). 2 Having area less then 5cm length,5cm width and 3cm depth. 3 Patient having control diabetes.

Exclusion criteria

Exclusion criteria: 1 Known cases of HIV,Hepatitis B, any systemic disease except diabetes. 2 Patients suffering from wounds like:- -Excessive lose of tissue. -Tubercular ulcers. -Venous ulcers. -Malignant ulcers.

Design outcomes

Primary

MeasureTime frame
To assess the Decrease in sign and symptoms of Dushtavarna(infected wound) in term of parameters like swelling,discharge,pain,smell etcTimepoint: 2 weeks

Secondary

MeasureTime frame
To study the literature of Tilakalkadi lepa To observe the adverse effect if anyTimepoint: 78 weeks

Countries

India

Contacts

Public ContactDr T Srinivas

Yashwant Ayurvedic college

drsrinivast@gmail.com9503147698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026